Skip to main content
logo
Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
7.56
+2.18 (40.52%)
At close: Aug 12, 2025, 4:00 PM
7.19
-0.37 (-4.89%)
After-hours: Aug 12, 2025, 7:52 PM EDT

Innovid Revenue

In the year 2024, Zhengye Biotechnology Holding had annual revenue of 186.36M CNY, down -11.95%. Zhengye Biotechnology Holding had revenue of 91.41M in the half year ending December 31, 2024, a decrease of -33.24%.

Revenue (ttm)
186.36M CNY
Revenue Growth
-11.95%
P/S Ratio
13.52
Revenue / Employee
672,765 CNY
Employees
277
Market Cap
358.28M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024186.36M-25.30M-11.95%
Dec 31, 2023211.65M-48.62M-18.68%
Dec 31, 2022260.27M46.20M21.58%
Dec 31, 2021214.07M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ZYBT News

More News